The recent controversy surrounding a relatively new blood thinner called Pradaxa (dabigatran) centers not on the drug itself, but on the safety of the drug’s message. Brought to market as a superior product to the long-standing market leader, Coumadin (warfarin), Pradaxa is touted for its ability to treat atrial fibrillation without the inconvenience of frequent […]
This week, the second-largest drugstore chain CVS Caremark Corp. (CVS) announced that it will stop selling tobacco products in its 7,600 pharmacies starting on October 1. The medical and tobacco control advocacy organizations applaud the decision, as it contributes to combatting tobacco consumption in the U.S. and exerts pressure on competitors to do the same. […]
Posted in Health reform, National Healthcare, Tobacco; Tagged: ACA, access to health care, CVS, National Healthcare, Obamacare, pharmacies, president obama, retail clinics, retail health clinics, tobacco control.
Within public health, we have many victories to claim. Vaccinations – for example – have been and remain unmitigated successes. Yet, there are many public health interventions that have been instituted and promoted by public health advocates, medical doctors, and various pharmaceutical or medical device companies that have proven to be ineffective at improving health […]
After not being able to get his son to the doctor for a strep throat test, Rick Krieger established the first retail clinic at a local grocery chain in 2000. The idea was to address issues of access to health care and allow patients to obtain care and treatment for minor conditions “in a quick, […]
Posted in National Healthcare; Tagged: access to health care, Affordable Care Act, Cancer, cardiovascular diseases, chronic disease, chronic disease management, chronic respiratory diseases, Diabetes, health care provider, health care services, heart disease, medical home, NCDs, obesity, patient, preventative care, primary care, retail clinics, Rick Krieger, Target, Walmart.
The advent of big data has forced a sea change throughout the scientific research enterprise, shaking the industry’s fundamental attitude towards the data themselves. Data is now understood as the currency of research. Consequently, industry is warming to the new reality that legal norms once considered to drive business – confidential commercial information, trade secrets […]
In a decision that could save U.S. consumers and taxpayers billions of dollars a year, the Supreme Court ruled Monday that “pay-for-delay,” also known as “reverse payment” settlements, between name-brand and generics pharmaceutical companies are subject to antitrust laws. The seeds of the controversy were planted in 1984 with the passage of the Hatch-Waxman […]
Recently, the U.S. Supreme Court heard oral arguments in Association for Molecular Pathology v. Myriad Genetics, Case No. 11-725, on the eligibility of patenting the BRCA1 and BRCA2 genes, which identify hereditary breast and ovarian cancers. The Court granted certiorari to hear this case after a split developed among the United States circuit court of […]
This post was written by Madhu Chugh. Ms. Chugh is a scholar at the O’Neill Institute at Georgetown University Law Center and an attorney at Wilmer Cutler Pickering Hale and Dorr LLP. The views expressed in this post are the author’s alone and do not reflect the views of WilmerHale or the O’Neill Institute. Mitt […]
This post was written by former O’Neill Institute Research Assistant and current Georgetown Law 2L Dinesh Kumar, who attended day three’s morning session of the Supreme Court’s hearing on the Affordable Care Act. Every aspect of the Affordable Care Act (ACA) Supreme Court oral arguments has been dissected in the days following the historic hearings, […]
This post was authored by Rory O’Sullivan, Policy Director, from the Young Invincibles. The Department of Health and Human Services recently released final rules that apply the Affordable Care Act’s (ACA) consumer protections to college health plans starting in Fall 2012. College students will now receive the same basic consumer protections and benefits as all […]
Signup for our mailing list and stay up to date on the latest happenings at The O’Neill Institute
Or sign up for our RSS Feed
The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.